{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T07:08:51Z","timestamp":1788764931497,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jfas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Foot and Ankle Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1053\/j.jfas.2026.05.005","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:15:30Z","timestamp":1778602530000},"page":"165.e1-165.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["History of GLP-1 receptor agonists confer no improvement for Achilles tendon repairs: A national, propensity-matched comparison"],"prefix":"10.1053","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0586-1343","authenticated-orcid":false,"given":"Thriaksh","family":"Rajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9779-5118","authenticated-orcid":false,"given":"Kevin A.","family":"Schafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jfas.2026.05.005_bib0001","first-page":"289","article-title":"Recent developments in Achilles tendon risk-analyzing rupture factors for enhanced injury prevention and clinical guidance: current implications of regenerative medicine","volume":"49","author":"Sankova","year":"2024","journal-title":"J Orthop Transl"},{"issue":"6","key":"10.1053\/j.jfas.2026.05.005_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304197","article-title":"Incidence, demographics, characteristics and management of acute Achilles tendon rupture: an epidemiological study","volume":"19","author":"Briggs-Price","year":"2024","journal-title":"PLoS One"},{"key":"10.1053\/j.jfas.2026.05.005_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7445398","article-title":"Persistent deficits after an Achilles tendon rupture: a narrative review","volume":"2022","author":"Hoeffner","year":"2022","journal-title":"Transl Sports Med"},{"key":"10.1053\/j.jfas.2026.05.005_bib0004","doi-asserted-by":"crossref","first-page":"k5120","DOI":"10.1136\/bmj.k5120","article-title":"Operative treatment versus nonoperative treatment of Achilles tendon ruptures: systematic review and meta-analysis","volume":"364","author":"Ochen","year":"2019","journal-title":"The BMJ"},{"key":"10.1053\/j.jfas.2026.05.005_bib0005","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.addr.2014.11.015","article-title":"Biologics for tendon repair","volume":"84","author":"Docheva","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1053\/j.jfas.2026.05.005_bib0006","doi-asserted-by":"crossref","DOI":"10.1007\/s12178-025-09978-3","article-title":"The effects of GLP-1 agonists on musculoskeletal health and orthopedic care","author":"Gatto","year":"2025","journal-title":"Curr Rev Musculoskelet Med"},{"key":"10.1053\/j.jfas.2026.05.005_bib0007","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2147\/DMSO.S459060","article-title":"Metabolic syndrome and tendon disease: a comprehensive review","volume":"17","author":"Lai","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1053\/j.jfas.2026.05.005_bib0008","first-page":"121","article-title":"Targeting the GLP-1\/GLP-1R axis to treat osteoarthritis: a new opportunity?","volume":"32","author":"Meurot","year":"2022","journal-title":"J Orthop Transl"},{"issue":"1","key":"10.1053\/j.jfas.2026.05.005_bib0009","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1053\/j.jfas.2026.05.005_bib0010","doi-asserted-by":"crossref","DOI":"10.1007\/s12178-025-09978-3","article-title":"The effects of GLP-1 agonists on musculoskeletal health and orthopedic care","author":"Gatto","year":"2025","journal-title":"Curr Rev Musculoskelet Med"},{"key":"10.1053\/j.jfas.2026.05.005_bib0011","first-page":"1","article-title":"The glucagon-like peptide 1 receptor agonist Exendin-4 induces tenogenesis in human mesenchymal stem cells","volume":"120","author":"Abdulmalik","year":"2021","journal-title":"Differ Res Biol Divers"},{"issue":"10","key":"10.1053\/j.jfas.2026.05.005_bib0012","doi-asserted-by":"crossref","first-page":"13930","DOI":"10.1007\/s11356-021-16723-z","article-title":"Chronic exposure to lead acetate promotes changes in the alveolar bone of rats: microstructural and physical-chemical characterization","volume":"29","author":"Davis","year":"2022","journal-title":"Environ Sci Pollut Res Int"},{"issue":"23","key":"10.1053\/j.jfas.2026.05.005_bib0013","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038444","article-title":"Favorable liver and skeletal muscle changes in patients with MASLD and T2DM receiving glucagon-like peptide-1 receptor agonist: A prospective cohort study","volume":"103","author":"Kakegawa","year":"2024","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1053\/j.jfas.2026.05.005_bib0014","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.arthro.2024.09.057","article-title":"Lower risk of postoperative complications and rotator cuff retear associated with semaglutide use in patients with type II diabetes mellitus undergoing arthroscopic rotator cuff repair","volume":"41","author":"Seddio","year":"2025","journal-title":"Arthroscopy"},{"issue":"1","key":"10.1053\/j.jfas.2026.05.005_bib0015","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.RVW.23.00167","article-title":"Glucagon-like peptide-1 agonists: what the orthopaedic surgeon needs to know","volume":"12","author":"Chan","year":"2024","journal-title":"JBJS Rev"},{"issue":"1","key":"10.1053\/j.jfas.2026.05.005_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2025.100567","article-title":"Effect of glucagon-like peptide-1 receptor agonists in osteoarthritis: a systematic review of pre-clinical and human studies","volume":"7","author":"Cheng","year":"2025","journal-title":"Osteoarthr Cartil Open"},{"issue":"7624","key":"10.1053\/j.jfas.2026.05.005_bib0017","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1053\/j.jfas.2026.05.005_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2025.103453","article-title":"Association between autoimmune diseases and glucagon-like peptide-1 receptor agonists: a real-world evidence study","volume":"155","author":"Lee","year":"2025","journal-title":"J Autoimmun"},{"key":"10.1053\/j.jfas.2026.05.005_bib0019","article-title":"Total hip arthroplasty outcomes for developmental dysplasia of the hip versus primary osteoarthritis: older age increases medical, not surgical complications","volume":"69","author":"Rajan","year":"2025","journal-title":"J Clin Orthop Trauma"},{"key":"10.1053\/j.jfas.2026.05.005_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.blo.0000144475.05543.e7","article-title":"Wound complications after open achilles tendon repair: an analysis of risk factors","volume":"427","author":"Bruggeman","year":"2004","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"10.1053\/j.jfas.2026.05.005_bib0021","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/1071100719831371","article-title":"Postoperative complications following repair of acute achilles tendon rupture","volume":"40","author":"Stavenuiter","year":"2019","journal-title":"Foot Ankle Int"},{"issue":"1","key":"10.1053\/j.jfas.2026.05.005_bib0022","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/19417381221087246","article-title":"Achilles Tendon repairs: identification of risk factors for and economic impact of complications and reoperation","volume":"15","author":"Trivedi","year":"2022","journal-title":"Sports Health"},{"issue":"10","key":"10.1053\/j.jfas.2026.05.005_bib0023","article-title":"Validation of PROMIS physical function for evaluating outcome after acute achilles tendon rupture","volume":"9","author":"Ochen","year":"2021","journal-title":"Orthop J Sports Med"},{"issue":"4","key":"10.1053\/j.jfas.2026.05.005_bib0024","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.fas.2023.04.004","article-title":"A systematic review of the patient reported outcome measures utilized in level 1 randomized controlled trials involving achilles tendon ruptures","volume":"29","author":"Pearsall","year":"2023","journal-title":"Foot Ankle Surg"}],"container-title":["The Journal of Foot and Ankle Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1067251626001365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1067251626001365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T06:34:49Z","timestamp":1788762889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1067251626001365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1067251626001365"],"URL":"https:\/\/doi.org\/10.1053\/j.jfas.2026.05.005","relation":{},"ISSN":["1067-2516"],"issn-type":[{"value":"1067-2516","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"History of GLP-1 receptor agonists confer no improvement for Achilles tendon repairs: A national, propensity-matched comparison","name":"articletitle","label":"Article Title"},{"value":"The Journal of Foot and Ankle Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jfas.2026.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Foot and Ankle Surgeons. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}